Familial Eosinophilic Esophagitis (EoE) is a chronic allergic inflammatory condition of the esophagus with a strong genetic basis. Research has shown that EoE often clusters within families, suggesting genetic predisposition plays a significant role.
Familial Eosinophilic Esophagitis (EoE) is a chronic allergic inflammatory condition of the esophagus with a strong genetic basis. Research has shown that EoE often clusters within families, suggesting genetic predisposition plays a significant role. A recent study aimed to uncover specific genes linked to familial EoE by using two advanced techniques: whole exome sequencing (to analyze rare genetic variants) and RNA sequencing (to study gene expression).
The study analyzed 50 familial EoE cases from 21 extended families using exome sequencing and 43 cases from 18 nuclear families using RNA sequencing. Exome sequencing identified 189 rare genetic variants across 181 genes shared among affected family members. RNA sequencing revealed 698 genes with altered expression in EoE cases compared to healthy controls, indicating widespread changes in gene activity linked to the disease.
Three genes—MUC16, ADGRE1, and TENM3—stood out as strong candidates for EoE susceptibility. These genes not only carried rare variants shared by affected relatives but also showed abnormal expression patterns. Additionally, 36 other genes demonstrated partial variant sharing and differential expression, suggesting a complex polygenic nature of EoE.
Interestingly, some EoE-related genes were abnormally expressed in unaffected family members, hinting at a latent genetic predisposition or subclinical molecular changes. Many identified genes are involved in immune regulation, epithelial barrier function, and cell adhesion, processes central to EoE development.
This study supports a "multihit" model for familial EoE, where inherited genetic vulnerabilities interact with environmental or immune triggers to cause the disease. These findings offer insights into the genetic and molecular mechanisms underlying EoE and may guide future research and treatments.
Introduction: Barrett's esophagus (BE) is the principal precursor of esophageal adenocarcinoma. Early detection of neoplastic transformation is essential for preventing cancer progression. This review discusses basal crypt dysplasia (CD), an emerging histological entity that may...
Introduction: Assessing esophageal clearance after peroral endoscopic myotomy (POEM) is essential for evaluating treatment success in achalasia. Timed barium esophagram (TBE) is the current standard, but high-resolution impedance manometry (HRiM) may provide a radiation-free physiological...
Introduction: Magnetic sphincter augmentation (MSA) has emerged as an effective surgical option for patients with gastroesophageal reflux disease (GERD) who continue to experience symptoms despite medical therapy. By augmenting lower esophageal sphincter function while preserving...
Introduction: Helicobacter pylori infection affects more than half of the global population and remains a major cause of peptic ulcer disease, gastric mucosal inflammation, and gastric cancer. Successful eradication is a cornerstone of gastrointestinal practice,...
Introduction: Helicobacter pylori Infection eradication after prior treatment failure remains a major therapeutic challenge due to increasing antibiotic resistance, poor tolerability of multidrug regimens and declining adherence rates. Simplified rescue strategies with improved safety and...
Introduction Helicobacter pylori Infection eradication is widely accepted as a key strategy for prevention of Gastric Cancer. Large meta-analyses have consistently shown reductions in gastric cancer incidence following eradication therapy, supporting global screening and treatment...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.